Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Malignant Carcinoid Syndrome

fluorodeoxyglucose f18 has been researched along with Malignant Carcinoid Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basuroy, R; Ramage, JK; Srirajaskanthan, R1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Malignant Carcinoid Syndrome

ArticleYear
Neuroendocrine Tumors.
    Gastroenterology clinics of North America, 2016, Volume: 45, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chromogranin A; Digestive System Surgical Procedures; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Magnetic Resonance Imaging; Malignant Carcinoid Syndrome; Metastasectomy; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Serotonin; Tomography, X-Ray Computed

2016